Job Description

• Conduct _in vitro _assays, including biochemical, traditional cell culture and cardiomyocyte functional assays
• Use molecular & cellular biology and next generation sequencing technology to investigate mechanisms of drug-induced toxicity
• Collaborate with investigative toxicologists to make safer medicines 
• Provide hands on support for NGS library prep and sequencing data generation
• Validate new biomarkers for drug safety risk assessment

Qualifications

• Master's degree in molecular biology, pharmacology, toxicology, or a related discipline; new PhD candidate is a plus
• Experience with advanced cell culture approaches with cell lines, primary cells, and iPSC derived cells.   
• Cell and molecular biology skills including development of reporter assays, application of knock-out, knock-down technology, gene expression analysis, and biomarker assay development and validation. Experience with next generation sequencing and bioinformatics analysis is a plus.  
• Experience working in a matrixed team environment at a pharmaceutical company and/or CRO 
• Broad scientific knowledge including pharmacology, toxicology, pathology, physiology and biochemistry. 
• Strong interpersonal and organizational skills 
• Excellent oral and written communication skills 
• Authorization to work in the United States indefinitely without restriction or sponsorship

Additional Information

Position is full time, working Monday - Friday, 8:00 a.m. - 5:00 p.m.  Candidates currently living within a commutable distance of Cambridge, MA are encouraged to apply.

EUROFINS IS A M/F, DISABLED, AND VETERAN EQUAL EMPLOYMENT OPPORTUNITY AND AFFIRMATIVE ACTION EMPLOYER.